AP NEWS

Obalon Schedules Second Quarter 2018 Financial Results Conference Call for August 2, 2018 at 8:30 a.m. Eastern Time

July 24, 2018

SAN DIEGO, July 24, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it plans to release its second quarter 2018 financial results before the market opens on Thursday, August 2, 2018. The company will hold a conference call and simultaneous webcast at 8:30 AM, Eastern Time (5:30 AM Pacific Time) on Thursday, August 2, 2018 to discuss the company’s financial results and provide a business update. Interested parties may access the conference call by dialing (844) 889-7791 (U.S.) or (661) 378-9934 (international) using passcode 6384879. Media and individuals will be in a listen-only mode. Participants are asked to dial in a few minutes prior to the call to register for the event. The conference call will also be webcast live at: https://edge.media-server.com/m6/p/jud3fsps.

An archive of the webcast will be available for twelve months following the event on the Obalon Therapeutics website located at http://investor.obalon.com in the “News & Events” section.

About Obalon Therapeutics, Inc. Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss. The Obalon management team has over 150 combined years of experience in developing and commercializing novel medical technologies with a track record of financial and clinical excellence. For more information, please visit www.obalon.com.

For Obalon Therapeutics, Inc.

Investor Contact:William PlovanicChief Financial OfficerObalon Therapeutics, Inc.Office: +1 760 607 5103 wplovanic@obalon.com

Media:Megan DriscollEvolveMKDOffice Phone: +1 646 517 4220 mdriscoll@evolvemkd.com

AP RADIO
Update hourly